ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

NCI Plans Phase-Out Of K04 Career Awards

March 3, 1995

Funding opportunities listed.

March 26, 2004

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977